The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis
Open accessAbstract
Background: With advances in antiretroviral therapy, most deaths in people with HIV are now attributable to noncommunicable illnesses, especially cardiovascular disease. We determine the association between HIV and cardiovascular disease, and estimate the national, regional, and global burden of cardiovascular disease attributable to HIV. Methods: We conducted a systematic review across 5 databases from inception to August 2016 for longitudinal studies of cardiovascular disease in HIV infection. A random-effects meta-analysis across 80 studies was used to derive the pooled rate and risk of cardiovascular disease in people living with HIV. We then estimated the temporal changes in the population-attributable fraction and disability-adjusted life-years (DALYs) from HIV-associated cardiovascular disease from 1990 to 2015 at a regional and global level. National cardiovascular DALYs associated with HIV for 2015 were derived for 154 of the 193 United Nations member states. The main outcome measure was the pooled estimate of the rate and risk of cardiovascular disease in people living with HIV and the national, regional, and global estimates of DALYs from cardiovascular disease associated with HIV. Results: In 793 635 people living with HIV and a total follow-up of 3.5 million person-years, the crude rate of cardiovascular disease was 61.8 (95% CI, 45.8–83.4) per 10 000 person-years. In comparison with individuals without HIV, the risk ratio for cardiovascular disease was 2.16 (95% CI, 1.68–2.77). Over the past 26 years, the global population–attributable fraction from cardiovascular disease attributable to HIV increased from 0.36% (95% CI, 0.21%–0.56%) to 0.92% (95% CI, 0.55%–1.41%), and DALYs increased from 0.74 (95% CI, 0.44–1.16) to 2.57 (95% CI, 1.53–3.92) million. There was marked regional variation with most DALYs lost in sub-Saharan Africa (0.87 million, 95% CI, 0.43–1.70) and the Asia Pacific (0.39 million, 95% CI, 0.23–0.62) regions. The highest population-attributable fraction and burden were observed in Swaziland, Botswana, and Lesotho. Conclusions: People living with HIV are twice as likely to develop cardiovascular disease. The global burden of HIV-associated cardiovascular disease has tripled over the past 2 decades and is now responsible for 2.6 million DALYs per annum with the greatest impact in sub-Saharan Africa and the Asia Pacific regions. Clinical Trial Registration: URL: https://www.crd.york.ac.uk/prospero . Unique identifier: CRD42016048257.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HIV patients have been found to have a higher risk of cardiovascular events, which was even higher in patients treated with protease inhibitors (Friis‐Moller et al, 2007; Islam et al, 2012; Shah et al, 2018).”
From The struggle of a good friend getting old: cellular senescence in viral responses and therapy (2021) · cites this paper as Shah et al, 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Hassen Abate, K., Akinyemiju, T. F., et al. (2017) · JAMA · doi:10.1001/jama.2016.19043 · Cited by 2,381
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 974
Exposure to toxic chemical elements among people living with HIV/AIDS in Northern Tanzania
Nyanza, E. C., Kapiga, S., Nsanya, M. K., Willkens, M. A., Cichowitz, C., & Peck, R. N. (2024) · Environmental Research · doi:10.1016/j.envres.2024.119645 · Cited by 6
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function
Erlandson, K. M., Umbleja, T., Ribaudo, H. J., Schrack, J. A., Overton, E. T., Fichtenbaum, C. J., Fitch, K. V., Roa, J. C., Diggs, M. R., Wood, K., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae422 · Cited by 6
Cameron, D., Morrell, L. C., Kagoya, F., Kiggundu, J. B., Hutchinson, B. W., Twine, R., Schwartz, J. I., Muddu, M., Mutungi, G. N., Kayima, J., et al. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003423 · Cited by 6
Self-citationMsoka, T. F., Rogath, J., Guilder, G. P. V., Kapanda, G., Smulders, Y. M., van Furth, A. M., Bartlett, J. A., & van Agtmael, M. A. (2021) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s304982 · Cited by 6
Amusa, G., Osaigbovo, G. O., Imoh, L. C., & Awokola, B. I. (2021) · Journal of BioMedical Research and Clinical Practice · doi:10.46912/jbrcp.208 · Cited by 6
Cardinal, M. R., Durand, M., Chartrand‐Lefebvre, C., Soulez, G., Tremblay, C. L., Cloutier, G., & Study, F. T. C. H. A. A. C. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003016 · Cited by 6
Modern view on the problem of atherosclerosis in HIV-positive people
Alieva, A. M., Sozykin, A., Валерьевна, Л. В., Skripnichenko, E. A., Teplova, N. V., Batov, M. A., Nikitin, A. E., Shnakhova, L. M., Izimarieva, D. V., & Nikitin, I. G. (2022) · Russian Cardiology Bulletin · doi:10.17116/cardiobulletin20221702125 · Cited by 6
Li, M., Zhou, I. W., Trevillyan, J. M., Hearps, A. C., Zhang, A. L., & Jaworowski, A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.922497 · Cited by 6
Keikha, M., & Karbalaei, M. (2022) · Archives of Iranian Medicine · doi:10.34172/aim.2022.42 · Cited by 6
Bevilacqua, K., Brinkley, C., McGowan, J. P., Wallach, F. R., & Schwartz, R. M. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s382005 · Cited by 6
Birk, S. E., Baran, D. A., Campbell, R., Herre, J. M., Sadatsafavi, H., & Yehya, A. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2023.04.014 · Cited by 6
Berner-Rodoreda, A., Kanyama, C., Supady, A., & Bärnighausen, T. (2023) · Sustainable development goals series · doi:10.1007/978-3-031-33851-9_24 · Cited by 6
Sun, L., Luo, Y., Jia, X., Wang, H., Zhao, F., Zhang, L., Ju, B., Wang, H., Shan, D., He, Y., et al. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003326 · Cited by 6
Kintu, A., Sando, D. M., Guwatudde, D., Bahendeka, S., Kawungezi, P. C., Mutungi, G. N., Muyindike, W. R., Menzies, N. A., Okello, S., Danaei, G., et al. (2020) · Journal of Global Health Reports · doi:10.29392/001c.14377 · Cited by 6
Temu, T. M., Wagoner, J., Masyuko, S. J., O’Connor, A., Zifodya, J. S., Macharia, P. M., Wanjalla, C. N., Mogaka, J. N., Chohan, B. H., Omodi, V. M., et al. (2021) · AIDS · doi:10.1097/qad.0000000000002956 · Cited by 6
Osuji, N., Haberlen, S., Ashikaga, H., Brown, T. T., Feinstein, M. J., Witt, M. D., Magnani, J. W., Soliman, E. Z., Wu, K. C., & Post, W. S. (2021) · Medicine · doi:10.1097/md.0000000000026663 · Cited by 6
Bagchi, S., Kwapong, Y. A., Schär, M., Bonanno, G., Streeb, V., Lai, S., Gerstenblith, G., Weiss, R. G., & Hays, A. G. (2023) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003162 · Cited by 6
Self-citationPeterson, T. E., Baker, J. V., Wong, L.-Y., Rupert, A. W., Ntusi, N., Esmail, H., Wilkinson, R. J., Sereti, I., Meintjes, G., Ntsekhe, M., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12849 · Cited by 6
Pawlos, A., Broncel, M., Wlazłowska, E., Jabłonowska, E., & Gorzelak‐Pabiś, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244675 · Cited by 6
Desine, S., Gabriel, C. L., Smith, H., Antonetti, O. R., Wang, C., Calcutt, M. W., Doran, A. C., Silver, H. J., Nair, S., Terry, J. G., et al. (2023) · medRxiv · doi:10.1101/2023.06.05.23290990 · Cited by 6
Perkins, A., Awori, J. O., Jobe, M., Lucinde, R. K., Siemonsma, M., Oyando, R., Leon, D. A., Herrett, E. L., Prentice, A. M., Shah, A. S. V., et al. (2023) · NIHR Open Research · doi:10.3310/nihropenres.13509.1 · Cited by 6
Self-citationCoronary artery calcium and all-cause mortality in the Multicenter AIDS Cohort Study
Suzuki, T., Haberlen, S., Peterson, T. E., Palella, F. J., Budoff, M. J., Witt, M. D., Magnani, J. W., & Post, W. S. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119181 · Cited by 5
Myocardical Infarction in Young Adults: Revisiting Risk Factors and Atherothrombotic Pathways
Cojocaru, P. A., Ţieranu, M. L., Piorescu, M. T. L., Buciu, I. C., Belu, A. E., Cureraru, S. I., Țieranu, E. N., Moise, C. G., & Istrătoaie, O. (2025) · Medicina · doi:10.3390/medicina61091615 · Cited by 5
Subia, N., Awamura, T., Dean, L. S., Loftis, K., Gangcuangco, L. M. A., MacPherson, I. S., Chang, S. P., Chow, D. C., Shikuma, C. M., & Park, J. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf227 · Cited by 5
Persistent activation of monocytes/macrophages and cell senescence in SIV-infected macaques on ART
Chen, Y., Ding, X., Ray, S., Thirugnanam, S., Blair, R. V., Saied, A. A., Sukhanov, S., Kolls, J. K., KIM, W. Y., Delafontaine, P., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1788994 · Cited by 5
Lipinski, J., Margevicius, S. P., SCHLUCHTER, M. D., Wilson, D. L., McComsey, G. A., & Longenecker, C. T. (2019) · Antiviral Therapy · doi:10.3851/imp3389 · Cited by 5
Self-citationAlterations in Renin–Angiotensin System (RAS) Peptide Levels in Patients with HIV
Asante, I., Lu, A., Mitchell, B. I., Boisvert, W. A., Shikuma, C. M., Chow, D. C., & Louie, S. G. (2022) · Metabolites · doi:10.3390/metabo13010061 · Cited by 5
Safo, S. E., Haine, L., Baker, J. V., Reilly, C., Duprez, D. A., Neaton, J. D., Jain, M. K., Arenas‐Pinto, A., Polizzotto, M. N., Staub, T., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.027273 · Cited by 5
Drago, F., Soshnik‐Schierling, L., Cabling, M. L., Pattarabanjird, T., Desderius, B., Nyanza, E. C., Raymond, H. F., McNamara, C. A., Peck, R. N., & Shiau, S. (2023) · HIV Medicine · doi:10.1111/hiv.13524 · Cited by 5
Chidumwa, G., Mazibuko, L., Olivier, S., Rahman, K., Gareta, D., Aung, T. N., Busang, J., Herbst, K., Wong, E. B., Baisley, K. J., et al. (2023) · BMJ Public Health · doi:10.1136/bmjph-2023-000153 · Cited by 5
Qiao, N.-N., Fang, Q., Zhang, X., Ke, S., Wang, Z., Tang, G., Leng, R., & Fan, Y. (2024) · Alcohol · doi:10.1016/j.alcohol.2024.02.003 · Cited by 5
Wang, C., Yu, X., Ke, Y., Fu, Y., Luo, Y., Li, Y., Bi, Y., Chen, X., Li, L., Zhao, X., et al. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01668-23 · Cited by 5
Bouassa, R. M., Giorgini, G., Silvestri, C., Muller, C., Nallabelli, N., Alexandrova, Y., Durand, M., Tremblay, C. L., Far, M. E., Chartrand‐Lefebvre, C., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110456 · Cited by 5
HIV and Cardiovascular Disease
Chitimilla, S. K., & Chitimilla, A. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24629104709 · Cited by 6
Moshomo, T., Gaolathe, T., Ramotsababa, M., Molefe‐Baikai, O. J., Mogaetsho, E., Dintwa, E., Gala, P., Ponatshego, P., Bogart, L. M., Youssouf, N. F., et al. (2024) · Implementation Science Communications · doi:10.1186/s43058-024-00620-w · Cited by 5
Belda, E., Capeau, J., Zucker, J., Chatelier, E. L., Pons, N., Oñate, F. P., Quinquis, B., Alili, R., Fellahi, S., Katlama, C., et al. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-01978-5 · Cited by 6
Jachymek, M., Wójcik, Ł., Peregud‐Pogorzelska, M., Parczewski, M., Dembowska, A., & Aksak‐Wąs, B. (2024) · Vascular Health and Risk Management · doi:10.2147/vhrm.s472328 · Cited by 5
Zhang, L., Abohashem, S., Osborne, M. T., Naddaf, N., Park, R., Moore, K., Patrich, T., Deeks, S. G., Hsue, P. Y., & Tawakol, A. A. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002630 · Cited by 5
Saumoy, M., Yacovo, S. D., Pérez, S., Sánchez‐Quesada, J., Valdivielso, J. M., Subirana, I., Imaz, A., Tiraboschi, J. M., García, B., Ordóñez‐Llanos, J., et al. (2021) · HIV Medicine · doi:10.1111/hiv.13093 · Cited by 6
Kamari, V. E., Rodríguez, K. M. G., Moser, C., Currier, J. S., Kelesidis, T., Stein, J. H., Brown, T. T., Howell, S. K., Beisswenger, P. J., & McComsey, G. A. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab423 · Cited by 5
Cardiac adiposity as a modulator of cardiovascular disease in HIV
Bonou, M. S., Kapelios, C. J., Protogerou, A. D., Mavrogeni, S. I., Aggeli, C., Markousis‐Mavrogenis, G., Psichοgiou, M., & Barbetseas, J. D. (2021) · HIV Medicine · doi:10.1111/hiv.13166 · Cited by 5
Platelet-HIV: interactions and their implications
Whiteheart, S. W. (2022) · Platelets · doi:10.1080/09537104.2021.2019695 · Cited by 5
Peterson, T. E., Landon, C., Haberlen, S., Bhondoekhan, F., Plankey, M. W., Palella, F. J., Piggott, D. A., Margolick, J. B., Brown, T. T., Post, W. S., et al. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02835-y · Cited by 5
Human Immunodeficiency Virus Infection-Associated Cardiomyopathy and Heart Failure
Papamanoli, A., Muncan, B., Yoo, J., Psevdos, G., & Kalogeropoulos, A. P. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111760 · Cited by 6
Comparative performance of cardiovascular risk prediction models in people living with HIV
Tahir, I. S., Vos, A. G., Damen, J. A., Barth, R. E., Tempelman, H. A., Grobbee, D. E., Scheuermaier, K. D., Venter, F., & Klipstein‐Grobusch, K. (2022) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v23i1.1395 · Cited by 5
Sadinski, L. M., Westreich, D., Edmonds, A., Breger, T., Cole, S., Ramirez, C., Brown, T., Ofotokun, I., Konkle-Parker, D., Kassaye, S. G., et al. (2022) · AIDS (London) · doi:10.1097/qad.0000000000003461 · Cited by 3
Peng, X., Ding, H., Huo, H., Zheng, Y., Zhou, J., Li, H., Hou, Y., Li, X., Geng, W., Shang, H., et al. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28699 · Cited by 5
Graham, S. M., Nance, R. M., Chen, J., Wurfel, M. M., Hunt, P. W., Heckbert, S. R., Budoff, M. J., Moore, R. D., Jacobson, J. M., Martin, J. N., et al. (2023) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003207 · Cited by 5
HIV infection and cardiovascular pathology
Shekhovtsova, T. A., & Duplyakov, D. V. (2023) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2023-3370 · Cited by 5
A holistic framework to integrate HIV and cardiovascular disease care in sub-Saharan Africa
Rahim, F. O., Jain, B., Bloomfield, G. S., Jain, P. K., Rugakingira, A., Thielman, N. M., Sakita, F. M., & Hertz, J. T. (2023) · AIDS · doi:10.1097/qad.0000000000003604 · Cited by 5
Fragkou, P. C., Ikonomidis, I., Benas, D., Kavatha, D., Moschopoulos, C. D., Protopapas, K., Kostelli, G., Thymis, J., Mpirmpa, D., Galani, I., et al. (2023) · Viruses · doi:10.3390/v15071505 · Cited by 5
Bengtson, A. M., Madlala, H. P., Matjila, M. J., Goedecke, J. H., Cu‐Uvin, S., McGarvey, S. T., Werner, E. F., & Myer, L. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae093 · Cited by 7
Haile, M., Degelo, T., Menna, T., Mohammed, F., & Gidisa, B. (2024) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s447396 · Cited by 6
The relationship between HIV/AIDS and coronary heart disease: A bibliometric analysis
Cai, Q., Pan, W., Zhang, C., Zhang, X., Wang, C., Sun, Y., An, M., Pan, F., Xiao, J., & Pan, X. (2024) · Medicine · doi:10.1097/md.0000000000039831 · Cited by 5
Kobe, E. A., Thakkar, A., Matai, S., Akkaya, E., Pagidipati, N. J., McGarrah, R. W., Bloomfield, G. S., & Shah, N. P. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100888 · Cited by 6
Molecular imaging of cardiovascular inflammation and infection in people living with HIV infection
Lawal, I. O., Stoltz, A. C., & Sathekge, M. M. (2020) · Clinical and Translational Imaging · doi:10.1007/s40336-020-00370-4 · Cited by 5
Han, W. M., Ueaphongsukkit, T., Chattranukulchai, P., Siwamogsatham, S., Chaiteerakij, R., Sophonphan, J., Gatechompol, S., Ubolyam, S., Phonphithak, S., Ruxrungtham, K., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002585 · Cited by 5
Cardiovascular disease and HIV infection
Jachymek, M., Braksator, M., Parczewski, M., Peregud‐Pogorzelska, M., & Kaźmierczak, J. (2021) · HIV & AIDS Review · doi:10.5114/hivar.2021.107234 · Cited by 5
Li, Y., Wang, Z., Xia, H., & Ju, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.769740 · Cited by 5
Beydoun, N., & Feinstein, M. J. (2022) · Current Heart Failure Reports · doi:10.1007/s11897-022-00560-3 · Cited by 5
Molefe‐Baikai, O. J., Kebotsamang, K., Modisawakgomo, P., Tlhakanelo, J. T., Motlhatlhedi, K., Moshomo, T., Youssouf, N. F., Masupe, T., Gaolathe, T., Tapela, N. M., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-17651-6 · Cited by 5
Imaging modalities for cardiovascular phenotyping in asymptomatic people living with HIV
Bonou, M. S., Kapelios, C. J., Athanasiadi, E., Mavrogeni, S. I., Psichοgiou, M., & Barbetseas, J. D. (2021) · Vascular Medicine · doi:10.1177/1358863x20978702 · Cited by 5
The cost of care for people living with stable HIV in Croatia and the efficiency of EmERGE
Beck, E. J., Mandalia, S., Yfantopoulos, P., Jones, C. I., Bremner, S. A., Whetham, J., Benković, I., Zekan, Š., & Begovać, J. (2021) · Croatian Medical Journal · doi:10.3325/cmj.2021.62.542 · Cited by 5
Self-citationInflammatory Diseases and Risk of Atherosclerotic Cardiovascular Disease: A New Focus on Prevention
Quispe, R., Varghese, B. T., & Michos, E. D. (2022) · Contemporary cardiology · doi:10.1007/978-3-030-98824-1_13 · Cited by 5
Guiraud, V., Sauce, D., Bittar, R., Fernández, J., Thévenet, H., Teyssou, E., Alkouri, R., Bonnefont‐Rousselot, D., Marcelin, A., Cálvez, V., et al. (2025) · Infectious Diseases Now · doi:10.1016/j.idnow.2025.105040 · Cited by 4
Nweke, M., Ibeneme, S. C., Pillay, J. D., & Mshunqane, N. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1586019 · Cited by 5
Lucinde, R. K., Willkens, M. A., Issarow, B., Fadhil, S. P., Cichowitz, C., Ayieko, P., Kisigo, G., Venkatraman, S., Grosskurth, H., Krieger, A. C., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.043957 · Cited by 6
Statin Effects on Pericoronary Adipose Tissue Density in People With HIV
Foldyna, B., Hadžić, I., Mayrhofer, T., Karády, J., Taron, J., Kolossváry, M., Raghu, V. K., McCallum, S., Paradis, K., Diggs, M. R., et al. (2025) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2025.10.012 · Cited by 4
Murray, A., Louwman, N., Luk, A., Parker, A., Madyiwa, N., Parker, H., Woodward, K., Gallegos, C. F., Dorward, J., Stevens, R. J., et al. (2026) · Journal of the International AIDS Society · doi:10.1002/jia2.70101 · Cited by 4
Hanley, S., Moodley, D., Naidoo, M., & Brummel, S. S. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003387 · Cited by 4
Murphy, N. R., Crothers, K. A., Snidarich, M., Budak, J. Z., Brown, M. C., Weiner, B. J., Giustini, N., Caverly, T. J., Durette, K., DeCell, K., et al. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.07.147 · Cited by 4
Keniyopoullos, R., Khawaja, A. A., Boffito, M., & Emerson, M. (2024) · HIV Medicine · doi:10.1111/hiv.13738 · Cited by 4
Cutshaw, M. K., Harding, M., Davenport, C. A., & Okeke, N. L. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae752 · Cited by 4
Baluku, J. B., Karungi, D., Namanda, B., Namiiro, S. M., Katusabe, S., Angut, M. M., Nabwana, M., Olum, R., Bongomin, F., Nuwagira, E., et al. (2025) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2025.100523 · Cited by 4
Elendu, C., Otobrise, D. E., Blewusi, G. S., Iheanetu, N. A., Olaofe, P. A., Bob-Ume, N. C., Suleiman, J. A., Hassan, J. I., Ibikunle, B. I., Mordi, P., et al. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003465 · Cited by 4
Eshetu, B., Gedefie, A., Mulatie, Z., Alemayehu, E., Belete, M. A., Tekele, S. G., Gebretsadik, D., Ebrahim, H., Tilahun, M., Debash, H., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11212-x · Cited by 3
Coronary Heart Disease in HIV-Infected Patients
Arzhakova, M. A., Shekhovtsova, T. A., & Duplyakov, D. V. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2019-15-6-900-905 · Cited by 4
Díaz, A., Grand, M., Torrado, J., Salazar, F., Zócalo, Y., & Bia, D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.772912 · Cited by 4
Grand, M., Díaz, A., & Bia, D. (2022) · Current HIV Research · doi:10.2174/1570162x20666220126124149 · Cited by 6
Quiles, N. N., Balachandran, A. T., & Ortíz, A. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111797 · Cited by 4
Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation
Masip, J., Jorba, R., López-Dupla, M., Domingo, P., Pacheco, Y. M., García‐Pardo, G., Martínez, E., Viladés, C., Veloso, S., Alba, V., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158071 · Cited by 4
Association of HIV infection with clinical features and outcomes of patients with aortic aneurysms
Chehab, O., Kanj, A., Zeitoun, R., Mir, T., Shafi, I., Pahuja, M., Briasoulis, Α., Vasconcellos, H. D. D., Minhas, A., Varadarajan, V., et al. (2022) · Vascular Medicine · doi:10.1177/1358863x221122577 · Cited by 4
Sakita, F. M., Prattipati, S., Chick, J., Samu, L. P., Maro, A. V., Coaxum, L. A., Galson, S. W., Samuel, D. R., Limkakeng, A. T., O’Leary, P., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285472 · Cited by 4
Urina-Jassir, M., Patiño-Aldana, A. F., Herrera-Parra, L. J., Vargas, J. A. H., Trujillo-Cáceres, S. J., Valbuena‐Garcia, A. M., Acuña-Merchán, L. A., Urina‐Jassir, D., & Urina‐Triana, M. (2023) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2023.200205 · Cited by 4
Sakita, F. M., O’Leary, P., Prattipati, S., Kessy, M. S., Kilonzo, K., Mmbaga, B. T., Rugakingira, A., Manavalan, P., Thielman, N. M., Samuel, D. R., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001929 · Cited by 4
PCSK9 Inhibitors—A New Hope for Dyslipidemia in HIV
Datla, S., & Kumar, S. (2023) · Cardiology in Review · doi:10.1097/crd.0000000000000587 · Cited by 4
Jiménez‐Yuste, V., Oldenburg, J., Tzeng, E., Lim, E., Sanabria, F., & Mahlangu, J. N. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102405 · Cited by 4
Ramos, S. R., Kang, B., Jeon, S., Fraser, M. A., Kershaw, T., & Boutjdir, M. (2024) · Nursing Reports · doi:10.3390/nursrep14030143 · Cited by 4
Kuniholm, M. H., Murenzi, G., Shumbusho, F., Brazier, E., Plaisy, M. K., Mensah, E., Wandeler, G., Riebensahm, C., Chihota, B., Samala, N. R., et al. (2024) · AIDS · doi:10.1097/qad.0000000000004012 · Cited by 4
Treatment of prehypertension among adults with HIV
Yan, L. D., Rouzier, V., Sufra, R., Sauveur, R. S., Guiteau, C., Lee, M., Ogyu, A., Mourra, N., Oparil, S., Théard, M., et al. (2024) · AIDS · doi:10.1097/qad.0000000000004065 · Cited by 4
Chen, S., Xu, Y., Jiang, Y., Chen, H., Wu, X., Qian, Z., Xu, X., Zhong, H., Peng, J., & Cai, S. (2024) · Virology Journal · doi:10.1186/s12985-024-02592-8 · Cited by 4
Elvstam, O., Ryom, L., Neesgaard, B., Tau, L., Günthard, H. F., Zangerle, R., Vehreschild, J. J., Wit, F. W. N. M., Sönnerborg, A. B., Kovari, H., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf016 · Cited by 4
Diggs, M. R., Umbleja, T., McCallum, S., Zanni, M. V., Chu, S. M., Fitch, K. V., Bloomfield, G. S., Currier, J. S., Martínez, E., Castle, P. E., et al. (2025) · The Lancet HIV · doi:10.1016/s2352-3018(24)00345-x · Cited by 4
Kwesiga, J. M., Nkonge, R., Namanda, B., Nabwana, M., & Baluku, J. B. (2025) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361251347698 · Cited by 4
Impact of team‐based care on appropriate statin therapy prescribing in ***HIV‐infected patients
Hester, E. K., Caulder, C. R., & Penzak, S. R. (2020) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1206 · Cited by 4
Methamphetamine and cardiac disease among people with HIV infection
Martin, T., Gianella, S., Franklin, D. R., Hsue, P. Y., & Smith, D. (2020) · HIV Medicine · doi:10.1111/hiv.12918 · Cited by 4
Bursztyn, M., & Israel, S. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13976 · Cited by 3
Zhu, Z., Li, T., Chen, J., Kumar, J., Kumar, P. N., Qin, J., Hadigan, C. M., Sereti, I., Baker, J. V., & Catálfamo, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663412 · Cited by 4
Mueller, M. C., Usadel, S., Kern, W. V., Zirlik, A., & Zhou, Q. (2021) · International Journal of STD & AIDS · doi:10.1177/09564624211029392 · Cited by 4
Dardano, A., Aragona, M., Daniele, G., Miccoli, R., & Prato, S. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.847778 · Cited by 4
Metadata
- Authors
- Shah, A. S. V., Stelzle, D., Lee, K. K., Beck, E. J., Alam, S., Clifford, S., Longenecker, C. T., Strachan, F., Bagchi, S., Whiteley, W., Rajagopalan, S., Kottilil, S., Nair, H., Newby, D. E., McAllister, D. A., & Mills, N. L.
- Affiliations
- University of Edinburgh (GB)
- Joint United Nations Programme on HIV/AIDS (CH)
- Case Western Reserve University (US)
- University of Maryland, Baltimore (US)
- University of Glasgow (GB)
- ORCID
- Venue
- Circulation
- Published
- 2018-09-11
- Volume
- 138
- Issue
- 11
- Pages
- 1100-1112
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC6221183
- OpenAlex
- W3025713364
- Cited by
- 975
- References
- 60
- Citations by year
- 2026: 139 · 2025: 153 · 2024: 159 · 2023: 117 · 2022: 137 · 2021: 111 · 2020: 99 · 2019: 51 · 2018: 8
- FWCI
- 82.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Wellcome Trust (201492/Z/16/Z)
- British Heart Foundation (FS/18/25/33454, FS/16/14/32023)
- University of Glasgow
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- HIV-associated cardiovascular disease, atherosclerotic cardiovascular disease, global burden of disease, disability-adjusted life years, population attributable fraction, people living with HIV, antiretroviral therapy, sub-Saharan Africa, cardiovascular risk, non-communicable diseases, cardiovascular risk factors
- MeSH terms
- Adult, Female, Humans, Male, Middle Aged, Prognosis, Risk Factors, Time Factors, Global Health, HIV Infections, Incidence, Prevalence, Cost of Illness, Risk Assessment, HIV Long-Term Survivors, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
